BactiVac is one of five Global Vaccine Networks that were established in 2017 to help UK and international researchers share knowledge and experience with the aim of accelerating the development of new or improved vaccines through pump-priming projects, training fellowships and events for network members. The networks have grown substantially since their establishment, in close partnership with LMIC researchers and supporting exciting new science and collaborations. Their crucial work will now be supported for a further two years with £6.3M of funding granted by UKRI, from the Government’s International Science Partnerships Fund.
The vital collaborations initiated by the networks are already addressing significant illnesses and causes of death in humans and animals with high economic and social effects, particularly in LMICs. The development of vaccines to tackle infectious diseases reduces the need for antibiotics and therefore also helps tackle the challenge of antimicrobial resistance, one of the top global health threats according to the World Health Organisation (WHO).
The five Global Vaccine Networks are; Bacterial Vaccines Network, International Veterinary Vaccinology Network, Human Infection Challenge network, IMmunising PRegnant Women and INfants network and Vaccine Development for Complex Intracellular Neglected Pathogens.
